Acetylation of HMGB1 by JNK1 Signaling Promotes LPS-Induced Peritoneal Mesothelial Cells Apoptosis.

作者: Shirong Cao , Shu Li , Yating Wang , Jiani Shen , Yi Zhou

DOI: 10.1155/2018/2649585

关键词:

摘要: Increased high mobility group box 1 (HMGB1) in dialysis effluence is associated with the presence of peritoneal dialysis-related peritonitis patients and dysfunction acute mice model, but it remains unclear whether HMGB1 involved mesothelial cell injury functions via molecular posttranslational modifications by acetylation this process. Here we first showed correlation between level occurrence Gram-negative peritonitis. The increased acetylated was similarly observed under lipopolysaccharides (LPS) treatment both human line (HMrSV5) visceral peritoneum tissue. Overexpression wild-type, not hypoacetylation mutant HMGB1, enhanced LPS-induced apoptosis HMrSV5 cells, which accompanied elevated protein levels BAX cleaved-caspase 3 compared to control. Pretreatment JNK inhibitor attenuated acetylation. Consistently, primary cells from Jnk1-/- a lower contents fewer apoptosis, decreased expression cleaved-caspase3 after LPS exposure, as those wild-type mice. In conclusion, our data demonstrated promotes JNK1-mediated upregulation

参考文章(38)
Elia Ranzato, Simona Martinotti, Mauro Patrone, Emerging roles for HMGB1 protein in immunity, inflammation, and cancer. ImmunoTargets and Therapy. ,vol. 4, pp. 101- 109 ,(2015) , 10.2147/ITT.S58064
Steven E. Mutsaers, Kimberly Birnie, Sally Lansley, Sarah E. Herrick, Chuan-Bian Lim, Cecilia M. Prêle, Mesothelial cells in tissue repair and fibrosis. Frontiers in Pharmacology. ,vol. 6, pp. 113- 113 ,(2015) , 10.3389/FPHAR.2015.00113
Helena Erlandsson Harris, Ulf Andersson, David S. Pisetsky, HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease Nature Reviews Rheumatology. ,vol. 8, pp. 195- 202 ,(2012) , 10.1038/NRRHEUM.2011.222
H. Yang, H. S. Hreggvidsdottir, K. Palmblad, H. Wang, M. Ochani, J. Li, B. Lu, S. Chavan, M. Rosas-Ballina, Y. Al-Abed, S. Akira, A. Bierhaus, H. Erlandsson-Harris, U. Andersson, K. J. Tracey, A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release Proceedings of the National Academy of Sciences of the United States of America. ,vol. 107, pp. 11942- 11947 ,(2010) , 10.1073/PNAS.1003893107
Richard S. Goldstein, Margot Gallowitsch-Puerta, LiHong Yang, Mauricio Rosas-Ballina, Jared M. Huston, Christopher J. Czura, David C. Lee, Mae F. Ward, Annette N. Bruchfeld, Haichao Wang, Martin L. Lesser, Adam L. Church, Adam H. Litroff, Andrew E. Sama, Kevin J. Tracey, Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock. ,vol. 25, pp. 571- 574 ,(2006) , 10.1097/01.SHK.0000209540.99176.72
Yangwei Wang, Yonggang Wang, Manyu Luo, Hao Wu, Lili Kong, Ying Xin, Wenpeng Cui, Yunjie Zhao, Jingying Wang, Guang Liang, Lining Miao, Lu Cai, Novel curcumin analog C66 prevents diabetic nephropathy via JNK pathway with the involvement of p300/CBP-mediated histone acetylation Biochimica et Biophysica Acta. ,vol. 1852, pp. 34- 46 ,(2015) , 10.1016/J.BBADIS.2014.11.006
Sabine Wolter, Anneke Doerrie, Axel Weber, Heike Schneider, Elke Hoffmann, Juliane Von Der Ohe, Latifa Bakiri, Erwin F Wagner, Klaus Resch, Michael Kracht, None, c-Jun Controls Histone Modifications, NF-κB Recruitment, and RNA Polymerase II Function To Activate the ccl2 Gene Molecular and Cellular Biology. ,vol. 28, pp. 4407- 4423 ,(2008) , 10.1128/MCB.00535-07
Tetsuya Ueda, Michiteru Yoshida, HMGB proteins and transcriptional regulation Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. ,vol. 1799, pp. 114- 118 ,(2010) , 10.1016/J.BBAGRM.2009.11.005
Zhanguo Gao, Jin Zhang, Indu Kheterpal, Norm Kennedy, Roger J. Davis, Jianping Ye, Sirtuin 1 (SIRT1) Protein Degradation in Response to Persistent c-Jun N-terminal Kinase 1 (JNK1) Activation Contributes to Hepatic Steatosis in Obesity Journal of Biological Chemistry. ,vol. 286, pp. 22227- 22234 ,(2011) , 10.1074/JBC.M111.228874
Anthony M. Manning, Roger J. Davis, Targeting JNK for therapeutic benefit: from junk to gold? Nature Reviews Drug Discovery. ,vol. 2, pp. 554- 565 ,(2003) , 10.1038/NRD1132